Alkermes plc.
ALKS
54 insider filings · Latest: Aug 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 1 8:22 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $33.40 | $300.6K | — | View → |
| Apr 6, 2026 | Apr 6 11:56 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sale | 2,034 | $34.57 | $70.3K | 233,592(D) | View → |
| Apr 6, 2026 | Apr 6 8:16 PM | Gaffin David Joseph | Proposed Sale | 2,034 | $34.57 | $70.3K | — | View → |
| Apr 1, 2026 | Apr 1 10:58 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sale | 9,000 | $35.51 | $319.6K | 85,389(D) | View → |
| Apr 1, 2026 | Apr 1 8:13 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $35.51 | $319.6K | — | View → |
| Mar 2, 2026 | Mar 5 1:19 AM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Sale | 6,890 | $29.29 | $201.8K | 7,717(D) | View → |
| Mar 2, 2026 | Mar 5 1:18 AM | Christian Todd NicholsSVP, Chief Commercial Officer | Sale | 6,000 | $30.00 | $180.0K | 109,769(D) | View → |
| Mar 2, 2026 | Mar 5 1:16 AM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sale | 9,000 | $29.72 | $267.5K | 89,389(D) | View → |
| Mar 3, 2026 | Mar 5 1:15 AM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sale | 2,034 | $29.76 | $60.5K | 235,626(D) | View → |
| Mar 2, 2026 | Mar 5 1:15 AM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sale | 2,034 | $29.29 | $59.6K | 237,660(D) | View → |
| Mar 3, 2026 | Mar 3 10:12 PM | Gaffin David Joseph | Proposed Sale | 2,034 | $29.76 | $60.5K | — | View → |
| Mar 2, 2026 | Mar 2 10:15 PM | Nichols Christian Todd | Proposed Sale | 6,000 | $30.00 | $180.0K | — | View → |
| Mar 2, 2026 | Mar 2 10:07 PM | Gaffin David Joseph | Proposed Sale | 2,034 | $29.29 | $59.6K | — | View → |
| Mar 2, 2026 | Mar 2 9:36 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $29.72 | $267.5K | — | View → |
| Feb 2, 2026 | Feb 3 1:52 AM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sale | 9,000 | $33.93 | $305.4K | 57,740(D) | View → |
| Feb 2, 2026 | Feb 3 1:48 AM | Shane CookeDirector | Sale | 61,200 | $34.57 | $2.1M | 103,744(D) | View → |
| Feb 2, 2026 | Feb 2 9:05 PM | Cooke Shane | Proposed Sale | 61,200 | $34.57 | $2.1M | — | View → |
| Feb 2, 2026 | Feb 2 9:02 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $33.93 | $305.4K | — | View → |
| Jan 8, 2026 | Jan 9 12:38 AM | Hopkinson Craig C. | Proposed Sale | 5,000 | $30.00 | $150.0K | — | View → |
| Jan 2, 2026 | Jan 2 9:36 PM | Hopkinson Craig C. | Proposed Sale | 4,000 | $28.00 | $112.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Feb 25 10:49 PM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option Exercise | 2,283 | — | 2,284(D) | View → |
| Feb 23, 2026 | Feb 25 10:48 PM | Christian Todd NicholsSVP, Chief Commercial Officer | Option Exercise | 6,407 | — | 6,408(D) | View → |
| Feb 23, 2026 | Feb 25 10:47 PM | Blair Curtis JacksonEVP, Chief Operating Officer | Option Exercise | 8,738 | — | 8,738(D) | View → |
| Feb 23, 2026 | Feb 25 10:46 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 7,689 | — | 7,690(D) | View → |
| Feb 23, 2026 | Feb 25 10:44 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option Exercise | 7,689 | — | 7,690(D) | View → |
| Feb 19, 2026 | Feb 20 9:25 PM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option Exercise | 2,991 | — | 8,974(D) | View → |
| Feb 18, 2026 | Feb 20 9:25 PM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option Exercise | 2,034 | — | 0(D) | View → |
| Feb 19, 2026 | Feb 20 9:24 PM | Christian Todd NicholsSVP, Chief Commercial Officer | Option Exercise | 6,045 | — | 18,137(D) | View → |
| Feb 18, 2026 | Feb 20 9:24 PM | Christian Todd NicholsSVP, Chief Commercial Officer | Option Exercise | 6,355 | — | 0(D) | View → |
| Feb 19, 2026 | Feb 20 9:23 PM | Blair Curtis JacksonEVP, Chief Operating Officer | Option Exercise | 9,300 | — | 27,903(D) | View → |
| Feb 18, 2026 | Feb 20 9:23 PM | Blair Curtis JacksonEVP, Chief Operating Officer | Option Exercise | 8,897 | — | 0(D) | View → |
| Feb 19, 2026 | Feb 20 9:22 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 7,673 | — | 23,019(D) | View → |
| Feb 18, 2026 | Feb 20 9:22 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 8,897 | — | 0(D) | View → |
| Feb 19, 2026 | Feb 20 9:20 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option Exercise | 7,673 | — | 23,019(D) | View → |
| Feb 18, 2026 | Feb 20 9:20 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option Exercise | 6,355 | — | 0(D) | View → |
| Feb 2, 2026 | Feb 3 1:52 AM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 5,000 | $19.34 | 26,356(D) | View → |
| Feb 2, 2026 | Feb 3 1:48 AM | Shane CookeDirector | Option Exercise | 61,200 | $31.64 | 0(D) | View → |
← Previous
Page 3 of 3